Citigroup
SPTX icon

Citigroup’s Seaport Therapeutics SPTX Stock Holding History

Citigroup’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$138K Buy
6,820
+4,366
+178% +$97K ﹤0.01% 4369
2026
Q2 		$53.3K Buy
+2,454
New +$43.2K ﹤0.01% 4953

Other funds holding SPTX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Citigroup's SPTX Position: Q3 2026 in Review

Citigroup increased its Seaport Therapeutics (SPTX) stake by 178% in Q3 2026, buying an estimated $97K and bringing the position to 6,820 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #4369.

Citigroup first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • Citigroup held 6,820 shares of Seaport Therapeutics worth $138K as of Q3 2026.
  • Citigroup bought 4,366 Seaport Therapeutics shares in Q3 2026, an estimated $97K.
  • Seaport Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4369 holding.
  • Citigroup first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 13 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.